Literature DB >> 21963866

The CC chemokine receptor 5 regulates olfactory and social recognition in mice.

Y V Kalkonde1, R Shelton, M Villarreal, J Sigala, P K Mishra, S S Ahuja, E Barea-Rodriguez, P Moretti, S K Ahuja.   

Abstract

Chemokines are chemotactic cytokines that regulate cell migration and are thought to play an important role in a broad range of inflammatory diseases. The availability of chemokine receptor blockers makes them an important therapeutic target. In vitro, chemokines are shown to modulate neurotransmission. However, it is not very clear if chemokines play a role in behavior and cognition. Here we evaluated the role of CC chemokine receptor 5 (CCR5) in various behavioral tasks in mice using Wt (Ccr5⁺/⁺) and Ccr5-null (Ccr5⁻/⁻)mice. Ccr5⁻/⁻ mice showed enhanced social recognition. Administration of CC chemokine ligand 3 (CCL3), one of the CCR5-ligands, impaired social recognition. Since the social recognition task is dependent on the sense of olfaction, we tested olfactory recognition for social and non-social scents in these mice. Ccr5⁻/⁻ mice had enhanced olfactory recognition for both these scents indicating that enhanced performance in social recognition task could be due to enhanced olfactory recognition in these mice. Spatial memory and aversive memory were comparable in Wt and Ccr5⁻/⁻ mice. Collectively, these results suggest that chemokines/chemokine receptors might play an important role in olfactory recognition tasks in mice and to our knowledge represents the first direct demonstration of an in vivo role of CCR5 in modulating social behavior in mice. These studies are important as CCR5 blockers are undergoing clinical trials and can potentially modulate behavior. Copyright Â
© 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21963866      PMCID: PMC3210349          DOI: 10.1016/j.neuroscience.2011.09.039

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  46 in total

Review 1.  Chemokines and chemokine receptors: new actors in neuroendocrine regulations.

Authors:  William Rostène; Alice Guyon; Lara Kular; David Godefroy; Federica Barbieri; Adriana Bajetto; Ghazal Banisadr; Céline Callewaere; Gregory Conductier; Carole Rovère; Stéphane Mélik-Parsadaniantz; Tullio Florio
Journal:  Front Neuroendocrinol       Date:  2010-07-17       Impact factor: 8.606

2.  Long-term memory underlying hippocampus-dependent social recognition in mice.

Authors:  J H Kogan; P W Frankland; A J Silva
Journal:  Hippocampus       Date:  2000       Impact factor: 3.899

3.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Authors:  T B Halene; R S Ehrlichman; Y Liang; E P Christian; G J Jonak; T L Gur; J A Blendy; H C Dow; E S Brodkin; F Schneider; R C Gur; S J Siegel
Journal:  Genes Brain Behav       Date:  2009-05-08       Impact factor: 3.449

4.  Chronic exposure to the chemokine CCL3 enhances neuronal network activity in rat hippocampal cultures.

Authors:  M Kuijpers; K L I van Gassen; P N E de Graan; D Gruol
Journal:  J Neuroimmunol       Date:  2010-08-01       Impact factor: 3.478

5.  Social amnesia in mice lacking the oxytocin gene.

Authors:  J N Ferguson; L J Young; E F Hearn; M M Matzuk; T R Insel; J T Winslow
Journal:  Nat Genet       Date:  2000-07       Impact factor: 38.330

6.  Cytokine-associated emotional and cognitive disturbances in humans.

Authors:  A Reichenberg; R Yirmiya; A Schuld; T Kraus; M Haack; A Morag; T Pollmächer
Journal:  Arch Gen Psychiatry       Date:  2001-05

7.  Social memory in mice: disruption with an NMDA antagonist and attenuation with antipsychotic drugs.

Authors:  Xue-Min Gao; Gregory I Elmer; Beverley Adams-Huet; Carol A Tamminga
Journal:  Pharmacol Biochem Behav       Date:  2008-12-10       Impact factor: 3.533

8.  A phase I study to explore the activity and safety of SCH532706, a small molecule chemokine receptor-5 antagonist in HIV type-1-infected patients.

Authors:  Sarah L Pett; Michael C McCarthy; David A Cooper; Karen MacRae; Amol Tendolkar; Richard Norris; Julie M Strizki; Kenneth M Williams; Sean Emery
Journal:  Antivir Ther       Date:  2009

9.  Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes.

Authors:  Juan E Belforte; Veronika Zsiros; Elyse R Sklar; Zhihong Jiang; Gu Yu; Yuqing Li; Elizabeth M Quinlan; Kazu Nakazawa
Journal:  Nat Neurosci       Date:  2009-11-15       Impact factor: 24.884

10.  Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptide.

Authors:  Giselle Fazzioni Passos; Cláudia Pinto Figueiredo; Rui Daniel Schröder Prediger; Pablo Pandolfo; Filipe Silveira Duarte; Rodrigo Medeiros; João B Calixto
Journal:  Am J Pathol       Date:  2009-09-03       Impact factor: 4.307

View more
  5 in total

Review 1.  Targeting C-C Chemokine Receptor 5: Key to Opening the Neurorehabilitation Window After Ischemic Stroke.

Authors:  Yi-Qi Feng; Zhen-Zhen Xu; Yan-Ting Wang; Yue Xiong; Wanli Xie; Yu-Yao He; Lu Chen; Guo-Yang Liu; Xia Li; Jie Liu; Qingping Wu
Journal:  Front Cell Neurosci       Date:  2022-04-28       Impact factor: 6.147

2.  Traffic of leukocytes and cytokine up-regulation in the central nervous system in a murine model of neuroparacoccidioidomycosis.

Authors:  Vinicius Sousa Pietra Pedroso; Márcia Carvalho Vilela; Patrícia Campi Santos; Patrícia Silva Cisalpino; Milene Alvarenga Rachid; Antônio Lúcio Teixeira
Journal:  Mycopathologia       Date:  2013-07-23       Impact factor: 2.574

3.  The Chemokine MIP-1α/CCL3 impairs mouse hippocampal synaptic transmission, plasticity and memory.

Authors:  Elodie Marciniak; Emilie Faivre; Patrick Dutar; Claire Alves Pires; Dominique Demeyer; Raphaëlle Caillierez; Charlotte Laloux; Luc Buée; David Blum; Sandrine Humez
Journal:  Sci Rep       Date:  2015-10-29       Impact factor: 4.379

Review 4.  Cellular, synaptic, and network effects of chemokines in the central nervous system and their implications to behavior.

Authors:  Joanna Ewa Sowa; Krzysztof Tokarski
Journal:  Pharmacol Rep       Date:  2021-08-26       Impact factor: 3.024

5.  A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure.

Authors:  Yasuhiro Ishihara; Tatsuya Honda; Nami Ishihara; Kaede Namba; Makiko Taketoshi; Yoko Tominaga; Mayumi Tsuji; Christoph F A Vogel; Takeshi Yamazaki; Kouichi Itoh; Takashi Tominaga
Journal:  J Neuroinflammation       Date:  2022-07-29       Impact factor: 9.587

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.